United Therapeutics Corp

NASDAQ:UTHR   1:53:13 PM EDT
224.92
+1.48 (+0.66%)
Earnings Announcements

United Therapeutics Corp Posts Total Q2 Revenue $466.9 Mln

Published: 08/03/2022 10:15 GMT
United Therapeutics Corp (UTHR) - Oration Reports Second Quarter 2022 Financial Results.
Total Revenues in Q2 of 2022 Grew 5% Year-over-year to $466.9 Million.
Q2 Revenue View $461.1 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Net Income per Common Share Basic $2.56.
Q2 Earnings per Share View $4.13 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $491.5 Million
Adjusted EPS is expected to be $4.27

Next Quarter Revenue Guidance is expected to be $501.36 Million
Next Quarter EPS Guidance is expected to be $4.05

More details on our Analysts Page.